Skip to content

Strengthening Exercises for Humeral Head Depressor Muscles

The Effect of Strengthening Exercises for Humeral Head Depressor Muscles on Clinical Outcomes After Reverse Shoulder Arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07309796
Enrollment
27
Registered
2025-12-30
Start date
2026-01-02
Completion date
2026-12-02
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reverse Shoulder Arthroplasty, Depressor Muscle Training, Shoulder Rehabilitation

Keywords

Reverse shoulder arthroplasty, Depressor muscle training. Shoulder, Arthroplasty

Brief summary

Postoperative rehabilitation after reverse shoulder arthroplasty aims to improve pain control, range of motion, and functional capacity. However, studies examining the effects of strengthening exercises targeting the humeral head depressor muscles are limited. This randomized controlled trial will evaluate the effects of adding a specific strengthening program to standard rehabilitation on pain, range of motion, quality of life, and functional outcomes.

Detailed description

Reverse shoulder arthroplasty (RSA) is an effective surgical method, particularly in cases of massive rotator cuff tears that lead to irreversible loss of shoulder function. The primary goals of postoperative rehabilitation are to reduce pain, improve shoulder joint functions, optimize scapulothoracic rhythm, and safely restore functional use. However, studies examining the effects of specific strengthening exercises targeting the humeral head depressor muscle group (latissimus dorsi, teres major, infraspinatus, etc.) on clinical outcomes are quite limited. This study aims to evaluate the effects of a specific strengthening protocol designed for the humeral head depressor muscles following reverse shoulder arthroplasty on pain, range of motion (ROM), quality of life, functional status, and psychological well-being. Planned as a randomized controlled trial, the research will apply an additional humeral head depressor muscle strengthening program to the standard conventional rehabilitation protocol in the experimental group, while the control group will receive only the standard rehabilitation program.

Interventions

After randomization and baseline assessments, participants will undergo a standard 6-week postoperative shoulder rehabilitation program, consisting of range-of-motion exercises, scapular stabilization training, and progressive strengthening. No additional depressor muscle-specific exercises will be applied.

OTHERDepressor Muscle Strengthening Group

After randomization and baseline assessments, participants will receive a 6-week rehabilitation program consisting of conventional postoperative shoulder rehabilitation combined with a specific strengthening protocol targeting the shoulder depressor muscles.

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Blinded assessor

Intervention model description

Randomized

Eligibility

Sex/Gender
ALL
Age
65 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for primary reverse total shoulder arthroplasty Intact teres minor confirmed by physical examination (Hornblower's test) and intraoperative assessment Ability to participate in physiotherapy or a home exercise program

Exclusion criteria

* Active infection Deltoid muscle insufficiency Inability or unwillingness to comply with randomization Prior shoulder arthroplasty on the same side Unwillingness to participate Inability to read or understand written instructions

Design outcomes

Primary

MeasureTime frameDescription
Pain Intensity (Visual Analog Scale - VAS)6 weeksPain intensity will be assessed using the Visual Analog Scale, a 10-cm line ranging from "no pain" to "worst imaginable pain." The distance from the "no pain" anchor to the participant's mark will be measured in millimeters (0-100 mm), with higher scores indicating higher pain intensity.
Upper Extremity Disability (Disabilities of the Arm, Shoulder and Hand Questionnaire - DASH)6 weeksThe DASH is a 30-item self-administered questionnaire assessing upper-extremity functional limitations. Items are scored 1-5 and converted to a 0-100 scale, where higher scores indicate greater disability.
Shoulder Range of Motion (ROM)6 weeksActive shoulder flexion, abduction, external rotation, and internal rotation will be measured using a standard goniometer. Results will be recorded in degrees (°).

Secondary

MeasureTime frameDescription
Shoulder Function (American Shoulder and Elbow Surgeons Score - ASES)6 weeksThe ASES score includes pain and functional assessments, yielding a total score between 0 and 100. Higher scores represent better shoulder function.
Thoracic Kyphosis Angle (Spinal Mouse Assessment)6 weeksThoracic spine curvature will be evaluated using the Spinal Mouse device during flexion and extension. The system provides non-invasive, objective measurements of thoracic kyphosis.
Pain Catastrophizing (Pain Catastrophizing Scale - PCS)6 weeksThe PCS consists of 13 items assessing rumination, magnification, and helplessness. Total scores range from 0 to 52, with higher scores indicating greater catastrophizing.
Anxiety and Depression (Hospital Anxiety and Depression Scale - HADS)6 weeksHADS includes 14 items (7 anxiety, 7 depression), each scored 0-3. Higher scores indicate higher levels of anxiety or depression.
Kinesiophobia (Tampa Scale of Kinesiophobia - TSK)6 weeksThe TSK is a 17-item tool measuring fear of movement and reinjury. Scores range between 17 and 68, with higher scores indicating greater kinesiophobia.
Quality of Life (12-Item Short-Form Health Survey - SF-12)6 weeksThe SF-12 generates Physical Component Summary (PCS) and Mental Component Summary (MCS) scores ranging from 0 to 100. Higher scores reflect better health-related quality of life.

Countries

Turkey (Türkiye)

Contacts

CONTACTCaner KARARTI, Assoc. Prof.
fzt.caner.92@gmail.com903862805362

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026